These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2866563)
21. Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia. Müller-Spahn F; Ackenheil M; Albus M; May G; Naber D; Welter D; Zander K Psychopharmacology (Berl); 1984; 84(3):436-40. PubMed ID: 6151210 [TBL] [Abstract][Full Text] [Related]
22. Apomorphine does not lower the concentration of homovanillic acid in the plasma of normal humans. Scheinin M Psychopharmacol Bull; 1984; 20(4):660-6. PubMed ID: 6494391 [No Abstract] [Full Text] [Related]
23. Dopaminergic responsivity during cocaine abstinence: a pilot study. McDougle CJ; Price LH; Palumbo JM; Kosten TR; Heninger GR; Kleber HD Psychiatry Res; 1992 Jul; 43(1):77-85. PubMed ID: 1359594 [TBL] [Abstract][Full Text] [Related]
24. Schneider's first-rank symptoms of schizophrenia. An association with increased growth hormone response to apomorphine. Whalley LJ; Christie JE; Brown S; Arbuthnott GW Arch Gen Psychiatry; 1984 Nov; 41(11):1040-3. PubMed ID: 6497565 [TBL] [Abstract][Full Text] [Related]
25. Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients. Davidson M; Kendler KS; Davis BM; Horvath TB; Mohs RC; Davis KL Psychiatry Res; 1985 Oct; 16(2):95-9. PubMed ID: 3865258 [TBL] [Abstract][Full Text] [Related]
35. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis. Csernansky JG; Vinogradov S; Prosser E; Kaplan J; Berger PA; Hollister LE Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311 [No Abstract] [Full Text] [Related]
36. Plasma levels of benperidol, prolactin, and homovanillic acid after intravenous versus two different kinds of oral application of the neuroleptic in schizophrenic patients. Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Benkert O; Hiemke C Exp Clin Endocrinol; 1994; 102(4):326-33. PubMed ID: 7813605 [TBL] [Abstract][Full Text] [Related]
37. Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin. Tripodianakis J; Markianos M; Garelis E Biol Psychiatry; 1983 Mar; 18(3):337-45. PubMed ID: 6132625 [TBL] [Abstract][Full Text] [Related]
38. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics. Duncan E; Wolkin A; Angrist B; Sanfilipo M; Wieland S; Cooper TB; Rotrosen J Biol Psychiatry; 1993 Oct; 34(8):523-8. PubMed ID: 8274579 [TBL] [Abstract][Full Text] [Related]
39. Growth hormone responses to graded doses of apomorphine HCl in schizophrenia. Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Mitton J Biol Psychiatry; 1983 Aug; 18(8):875-85. PubMed ID: 6137249 [TBL] [Abstract][Full Text] [Related]